Roche's Bold Leap: Pioneering Direct Patient Engagement for Enhanced Care

A New Era for Alzheimer's Diagnosis: FDA Approves First Blood Test

A New Dawn for Diagnostics: FDA Approves First Blood Test for Alzheimer's Disease

A New Dawn for Alzheimer's Diagnosis: FDA Approves Roche and Eli Lilly's Groundbreaking Blood Test

Amneal Pharmaceuticals Eyes Major Market Entry with Xolair Biosimilar, Pledging Affordable Relief

A New Dawn: Scientists Achieve Landmark Breakthrough in Treating Huntington's Disease

A New Dawn: UK Gene Therapy Trial Offers Unprecedented Hope for Huntington's Disease

Market Movers: Unpacking the Week's Most Impactful Corporate Deals and Strategic Shifts

Roche's Strategic Investment Ignites Excitement in the MASH Drug Development Landscape

Global Pharma Giants Set Sights on China: J&J and Roche Reportedly Eyeing Billion-Dollar Cancer Drug Deal with Henlius Biotech